Deprescribing: What is it and what does the evidence tell us?

Canadian Journal of Hospital Pharmacy

Volumn 66, Issue 3, 2013, Pages 201-202

  Thompson, Wade ^a,b   Farrell, Barbara ^a,b,c  

^a BRUYÈRE RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INAPPROPRIATE PRESCRIBING; LETTER; MORTALITY; PERSONAL EXPERIENCE; POLYPHARMACY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMATIC REVIEW;

EID: 84905723182     PISSN: 00084123     EISSN: 19202903     Source Type: Journal    
DOI: 10.4212/cjhp.v66i3.1261     Document Type: Letter

References (8)

1. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345-51.
2. Ziere G, Dieleman JP, Hofman A, Pols HAP, Van Der Cammen TJ, Stricker BHC. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2006;61(2):218-23.
3. Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging. 2009;26(12):1039-48.
4. Farrell B, Thompson W. The evidence for deprescribing: trials and tribulations [presentation]. Canadian Society of Hospital Pharmacists Professional Practice Conference; 2013 Feb 3-6; Toronto (ON).
5. Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28(2):237-53.
6. Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging. 2008;25(12):1021-31.
7. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc. 1999;47(7):850-3.
8. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new costeffective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J. 2007;9 (6):430-4.